Patent Assignment
Reel/Frame 030740/0123
Security Agreement
Recorded: 2013-07-03
Pages: 17
Assignor
MANNKIND CORPORATION
Executed: 2013-07-01
Assignees
DEERFIELD PRIVATE DESIGN FUND II, L.P.
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
HORIZON SANTE FLML SARL
780 THIRD AVENUE, 37TH FLOOR, NEW YORK, NEW YORK, 10017
Covered Properties
(124)
Diketopiperazine Salts for Drug Delivery and Related Methods
Catalysis of Diketopiperazine Synthesis
Potentiation of glucose elimination
Superior Control of Blood Glucose in Diabetes Treatment
Application:
13/077,361 →
Publication:
US US20110183901A1
Method of Preserving the Function of Insulin-Producing Cells
Application:
11/461,746 →
Publication:
US US20070027063A1
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
Glucagon-Like Peptide 1 (Glp-1) Pharmaceutical Formulations
Application:
11/735,957 →
Publication:
US US20080260838A1
Method of Preventing Adverse Effects by Glp-1
Application:
13/732,911 →
Publication:
US US20130125886A1
Method for Treating Hyperglycemia with GLP-1
Method for Treating Hyperglycemia
Inhalable Vaccine Compositions and Methods
Application:
61/719,308 →
Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome
A Method of Treating Diabetes Type 2 by Administering Ultrarapid Acting Insulin
Use of Ultrarapid Acting Insulin
Methods and Compositions for Delivering Peptides
Diketopiperazine Microparticles with Defined Specific Surface Areas
Diketopiperazine Microparticles with Defined Specific Surface Areas
Formation of N-Protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine
Methods for the synthesis of activated ethylfumarates and their use as intermediates
Application:
61/639,536 →
Methods for the Synthesis of Activated Ethylfumarates and Their Use as Intermediates
Formation of N-protected bis-3,6-(4-aminobutyl)-2,5-diketopiperazine Through a Cyclic N-Protected Active Amino Ester Intermediate
Application:
61/798,016 →
Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
Delivery of Active Agents
Application:
13/737,823 →
Publication:
US US20130118491A1
Method and Composition for Treating Migraines
Method and Composition for Treating Hyperglycemia
Application:
61/694,741 →
Microcrystalline Diketopiperazine Compositions and Methods
Application:
61/800,520 →
Unit Dose Capsules and Dry Powder Inhaler
Unit Dose Capsules and Dry Powder Inhaler
Unit Dose Cartridge and Dry Powder Inhaler
Dry Powder Inhalation System
Application:
12/413,405 →
Publication:
US US20090241949A1
Dry Powder Drug Delivery Systems and Methods
Application:
61/671,041 →
Dry Powder Inhaler and System for Drug Delivery
Dry Powder Inhaler and System for Drug Delivery
Dry Powder Inhaler and System for Drug Delivery
Dry powder drug delivery system
Dry Powder Drug Delivery System and Methods
Blister Package for Pharmaceutical Cartridges
Application:
61/470,982 →
Blister Package for Pharmaceutical Cartridges
Interactive Apparatus and Method for Real-Time Profiling of Inhalation Efforts
Apparatus, System and Method for Measuring Resistance of an Inhaler
Inhaler Adaptor for a Laser Diffraction Apparatus and Method for Measuring Particle Size Distribution
Inhalation Apparatus
Powder Dispensing and Sensing Apparatus and Methods
Powder Dispenser Modules and Powder Dispenser Assemblies
Reactor for Producing Pharmaceutical Particles in a Precipitation Process
Apparatus and Method for Cryogranulating a Pharmaceutical Composition
Determining Percent Solids in Suspension Using Raman Spectroscopy
Diketopiperazine Salts for Drug Delivery and Related Methods
Diketopiperazine Salts for Drug Delivery and Related Methods
Catalysis of Diketopiperazine Synthesis
Catalysis of Diketopiperazine Synthesis
Superior Control of Blood Glucose in Diabetes Treatment
Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces
Method of Drug Formulation of Compositions Comprising Crystalline Microparticle Surfaces
Method for Improving the Pharmaceutic Properties of Microparticles Comprising Diketopiperazine and an Active Agent
Method of Preventing Adverse Effects by Glp-1
A Method of Treating Diabetes Type 2 by Metformin and an Ultrarapid Acting Insulin
A Method of Controlling Glycemia by Ultrarapid Acting Insulin Without Adjusting an Insulin Dose for Meal Content
Diketopiperazine-Based Delivery Systems
Patent:
5,693,338 →
Application:
08/315,200 →
Diketopiperazine-Based Delivery Systems
Patent:
5,976,569 →
Application:
08/841,101 →
Carbon-Substituted Diketopiperazine Delivery Systems
Patent:
6,331,318 →
Application:
08/316,404 →
Carbon-Substituted Diketopiperazine Delivery Systems
Carbon-Substituted Diketopiperazine Delivery Systems
Carbon-Substituted Diketopiperazine Delivery Systems
Carbon-Substituted Diketopiperazine Delivery Systems
Carbon-Substituted Diketopiperazine Delivery Systems
Method for Drug Delivery to the Pulmonary System
Patent:
6,428,771 →
Application:
08/441,378 →
Method for Drug Delivery to the Pulmonary System
Patent:
6,071,497 →
Application:
08/847,352 →
Method for Drug Delivery to the Pulmonary System
Purification and Stabilization of Peptide and Protein Pharmaceutical Agents
Patent:
6,444,226 →
Application:
09/606,468 →
Purification and Stabilization of Peptide and Protein Pharmaceutical Agents
A Method for Delivery of Monomeric or Dimeric Insulin Complexed to Diketopiperazine Microparticles
Methods and Compositions for Delivering Peptides
Methods and Compositions for Delivering Peptides
Diketopiperazine Microparticles with Defined Isomer Contents
Substituted Diketopiperazine Analogs for Use as Drug Delivery Agents
Delivery of Active Agents
Dry Powder Formulations of Antihistamine for Nasal Administration
Dry Powder Formulations of Antihistamine for Nasal Administration
Methods for Fine Powder Formation
Multi-Spike Release Formulation for Oral Drug Delivery
Compositions for Treatment or Prevention of Bioterrorism
Unit Dose Capsules for Use in a Dry Powder Inhaler
Patent:
7,305,986 →
Application:
09/621,092 →
Unit Dose Capsules and Dry Powder Inhaler
Unit Dose Capsules and Dry Powder Inhaler
Unit Dose Cartridge and Dry Powder Inhaler
Unit Dose Cartridge and Dry Powder Inhaler
Dry Powder Inhaler and System for Drug Delivery
Dry Powder Inhaler
Patent:
635,241 →
Application:
29/319,775 →
Dry Powder Inhaler
Patent:
604,833 →
Application:
29/319,778 →
Catridge for a Dry Powder Inhaler
Patent:
605,753 →
Application:
29/319,776 →
Dry Powder Inhaler
Patent:
597,657 →
Application:
29/319,777 →
Dry Powder Inhaler
Patent:
605,752 →
Application:
29/319,774 →
Cartridge for a Dry Powder Inhaler
Patent:
604,832 →
Application:
29/319,773 →
Dry Powder Inhaler
Patent:
629,887 →
Application:
29/328,739 →
Dry Powder Inhaler
Patent:
629,888 →
Application:
29/328,744 →
Dry Powder Inhaler
Patent:
629,886 →
Application:
29/328,724 →
Dry Powder Inhaler
Patent:
635,243 →
Application:
29/328,742 →
Dry Powder Inhaler
Patent:
629,506 →
Application:
29/328,733 →
Dry Powder Inhaler
Patent:
635,242 →
Application:
29/328,728 →
Dry Powder Inhaler
Patent:
629,505 →
Application:
29/328,731 →
Cartridge for a Dry Powder Inhaler
Patent:
613,849 →
Application:
29/333,230 →
Cartridge for a Dry Powder Inhaler
Patent:
664,640 →
Application:
29/356,555 →
Dry Powder Inhaler
Patent:
614,760 →
Application:
29/333,232 →
Dry Powder Inhaler
Patent:
636,868 →
Application:
29/363,773 →
Dry Powder Inhaler
Patent:
636,869 →
Application:
29/363,775 →
Dry Powder Inhaler
Patent:
636,867 →
Application:
29/363,768 →
Inhaler Device
Patent:
674,893 →
Application:
29/404,464 →
Blister Packaging
Patent:
643,308 →
Application:
29/375,859 →
Blister Packaging
Patent:
671,842 →
Application:
29/394,877 →
Inhalation Apparatus
Inhalation Apparatus
Inhalation Apparatus
Powder Dispensing and Sensing Apparatus and Methods
Powder Dispensing and Sensing Apparatus and Methods
Powder Dispenser Modules and Powder Dispensing Methods
Powder Dispenser Modules and Powder Dispensing Methods
Powder Transport Systems and Methods
Powder Transport Systems and Methods
Powder Feed System
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 28, 2006
From: BOSS, ANDERS HASAGER; WOODS, RODNEY J.; SULNER, JOSEPH W.; STEINER, SOLOMON S.
To: MANNKIND CORPORATION
Reel/Frame 017549/0161 →
Assignment of Assignor's Interest
Oct 2, 2006
From: BOSS, ANDERS HASAGER; CHEATHAM, WAYMAN WENDELL; DIAMOND, DAVID C.
To: MANNKIND CORPORATION
Reel/Frame 018335/0299 →
Assignment of Assignor's Interest
Jul 5, 2007
From: HOKENSON, MARK J.; BRANDT, DAVID; KING, MARK; GREENE, STEPHANIE
To: MANNKIND CORPORATION
Reel/Frame 019518/0698 →
Assignment of Assignor's Interest
Jun 30, 2010
From: GRANT, MARSHALL L.; STOWELL, GRAYSON W.; MENKIN, PAUL
To: MANNKIND CORPORATION
Reel/Frame 024615/0724 →
Assignment of Assignor's Interest
Jul 19, 2010
From: OBERG, KEITH A.; SULNER, JOSEPH
To: MANNKIND CORPORATION
Reel/Frame 024704/0719 →
Assignment of Assignor's Interest
Sep 16, 2010
From: HOKENSON, MARK; OBERG, KEITH A.
To: MANNKIND CORPORATION
Reel/Frame 024997/0206 →
Assignment of Assignor's Interest
Mar 31, 2011
From: CHEATHAM, WAYMAN WENDELL; BOSS, ANDERS HASAGER
To: MANNKIND CORPORATION
Reel/Frame 026057/0533 →
Assignment of Assignor's Interest
Sep 19, 2011
From: COSTELLO, DONALD; RICHARDSON, PETER; BAUGHMAN, ROBERT A.; MARINO, MARK T.
To: MANNKIND CORPORATION
Reel/Frame 026925/0946 →
Assignment of Assignor's Interest
Sep 22, 2011
From: WILSON, BRYAN R.; GRANT, MARSHALL
To: MANNKIND CORPORATION
Reel/Frame 026947/0238 →
Assignment of Assignor's Interest
Jan 17, 2012
From: RICHARDSON, PETER; BAUGHMAN, ROBERT A.; POTOCKA, ELIZABETH; BOSS, ANDERS HASAGER
To: MANNKIND CORPORATION
Reel/Frame 027543/0963 →
Assignment of Assignor's Interest
Jan 25, 2012
From: BOSS, ANDERS HASAGER; PETRUCCI, RICHARD; HOWARD, CAMPBELL; MANN, ALFRED
To: MANNKIND CORPORATION
Reel/Frame 027591/0116 →
Assignment of Assignor's Interest
Mar 16, 2012
From: STEVENSON, JOHN J.; MOYE-SHERMAN, DESTARDI
To: MANNKIND CORPORATION
Reel/Frame 027880/0885 →
Assignment of Assignor's Interest
Jan 4, 2013
From: RICHARDSON, PETER; BAUGHMAN, ROBERT A.; COSTELLO, DONALD
To: MANNKIND CORPORATION
Reel/Frame 029570/0900 →
Assignment of Assignor's Interest
Jan 22, 2013
From: LEONE-BAY, ANDREA; MOYE-SHERMAN, DESTARDI; WILSON, BRYAN R.
To: MANNKIND CORPORATION
Reel/Frame 029668/0695 →
Change of Name
Feb 7, 2013
From: PHARMACEUTICAL DISCOVERY CORPORATION
To: MANNKIND CORPORATION
Reel/Frame 029775/0343 →
Assignment of Assignor's Interest
Feb 7, 2013
From: STEINER, SOLOMON S.; WOODS, RODNEY J.; SULNER, JOSEPH W
To: PHARMACEUTICAL DISCOVERY CORPORATION
Reel/Frame 029774/0371 →
Assignment of Assignor's Interest
Feb 21, 2014
From: HOKENSON, MARK; OBERG, KEITH A.
To: MANNKIND CORPORATION
Reel/Frame 032272/0442 →
Patent Security Agreement
Sep 26, 2014
From: MANNKIND CORPORATION
To: AVENTISUB LLC
Reel/Frame 033831/0110 →
Assignment of Assignor's Interest
Apr 22, 2015
From: SMUTNEY, CHAD C.; LEONE-BAY, ANDREA; GRANT, MARSHALL L.
To: MANNKIND CORPORATION
Reel/Frame 035468/0422 →
Assignment of Assignor's Interest
Apr 22, 2015
From: GALARZA, JOSE M.; MUNOZ, HECTOR; MARTIN, GEORGE R.
To: TECHNOVAX INC.
Reel/Frame 035468/0544 →
Release of Security Interest
Nov 10, 2016
From: AVENTISUB LLC
To: MANNKIND CORPORATION
Reel/Frame 040588/0008 →
Release of Security Interest
Aug 13, 2019
From: DEERFIELD PRIVATE DESIGN FUND II, L.P.; DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.; HORIZON SANTE FLML SARL
To: MANNKIND CORPORATION
Reel/Frame 050044/0138 →
Security Interest
Aug 13, 2019
From: MANNKIND CORPORATION; MANNKIND LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 050044/0181 →
Release of Security Interest
Apr 5, 2024
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: MANNKIND CORPORATION; MANNKIND LLC
Reel/Frame 067024/0082 →
Patent Security Agreement
Aug 12, 2025
From: MANNKIND CORPORATION
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 072444/0525 →